Recent advances in clinical practice: mastering the challenge—managing IBS symptoms in IBDJudith Wellens, João Sabino, Tim Vanuytsel, Jan Tack, Séverine Vermeire
12 November 2024
Where are we with gastric cancer screening in Europe in 2024?Mārcis Leja
4 September 2024
QUAIDE - Quality assessment of AI preclinical studies in diagnostic endoscopyGiulio Antonelli, Diogo Libanio, Albert Jeroen De Groof, Fons van der Sommen, Pietro Mascagni, Pieter Sinonquel, Mohamed Abdelrahim, Omer Ahmad, Tyler Berzin, Pradeep Bhandari, Michael Bretthauer, Miguel Coimbra, Evelien Dekker, Alanna Ebigbo, Tom EelbodeSee the full list of authors
15 October 2024
Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseasesArnau Vich Vila, Jingwan Zhang, Moting Liu, Klaas Nico Faber, Rinse K Weersma
13 July 2024
Acute severe ulcerative colitis trials: the past, the present and the futureSailish Honap, Vipul Jairath, Bruce E Sands, Parambir S Dulai, Silvio Danese, Laurent Peyrin-Biroulet
4 June 2024
‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatmentErwan Vo-Quang, Jean-Michel Pawlotsky
23 May 2024
Heavy arch: from inflammatory bowel diseases to metabolic disordersTimon E Adolph, Moritz Meyer, Almina Jukic, Herbert Tilg
22 May 2024
Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment targetAlexander C Ford, Heidi M Staudacher, Nicholas J Talley
2 May 2024
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkersJonel Trebicka, Ruben Hernaez, Debbie Lindsay Shawcross, Alexander L Gerbes
25 March 2024
Fibrosis in IBD: from pathogenesis to therapeutic targetsFlorian Rieder, Pranab K Mukherjee, William J Massey, Yan Wang, Claudio Fiocchi
17 January 2024